Dynamic Light Scattering Instrument Upgrade
Archived on October 6, 2026. Combined Synopsis/Solicitation posted by HEALTH AND HUMAN SERVICES, DEPARTMENT OF (NATIONAL INSTITUTES OF HEALTH) on September 15, 2026. Solicitation 75N98026Q01220.
NAICS 334516 (Analytical Laboratory Instrument Manufacturing). Place of performance: Bethesda, Maryland. Original response deadline: . Full description on SAM.gov.
Description
Title: Dynamic Light Scattering Instrument Upgrade
Solicitation No.: 75N98026Q01220
This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested, and a separate written solicitation will not be issued.
The solicitation number is 75N98026Q01220. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive acquisition and is intended to result in the award of a purchase order without providing for full and open competition.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services. The statutory authority for this non-competitive acquisition is 41 U.S.C. 1901, as implemented by FAR 6.302-3(a)(2)(ii), as applicable.
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a Firm-Fixed-Price Purchase Order on a non-competitive basis to:
Waters Technologies Corporation
34 Maple Street
Milford, MA 01757
for a Wyatt Systems DynaPro NanoStar II and associated upgrade/configuration, accessories, standards, installation, training, and technical support.
DESCRIPTION OF REQUIREMENT
The purpose of this acquisition is to replace an aging and failing dynamic light scattering (DLS) instrument currently used by the NIH laboratory. The existing Wyatt DLS instrument is approximately 16 years old and is well beyond its expected service life. In addition, degradation of the instrument's laser has significantly reduced its performance and rendered it unsuitable for many protein samples.
The Government requires a replacement system that provides reliable, high-sensitivity dynamic light scattering measurements while maintaining compatibility with the laboratory's existing Wyatt Systems infrastructure, workflows, and applications.
The proposed Wyatt Systems DynaPro NanoStar II provides combined Dynamic Light Scattering (DLS) and Static Light Scattering (SLS) capabilities. These complementary measurements provide information regarding particle size and molecular mass and will support characterization of protein complexes and higher-order assemblies relevant to ongoing NIH research involving viral nucleocapsid proteins and other biomolecular systems.
The system's broad measurement range, wide temperature range, small-volume sample capability, and rapid, non-destructive measurements are particularly important for research involving limited quantities of protein or samples that are difficult to produce. The ability to perform measurements using small sample volumes will help conserve valuable research materials and facilitate routine sample characterization.
The replacement instrument will also support collaborative research projects by providing an accessible and standardized method for screening sample quality before more resource-intensive analyses are undertaken. This capability is expected to improve laboratory efficiency, maximize the use of shared research resources, and enhance the reliability and reproducibility of experimental results.
Failure to replace the existing instrument would adversely affect mission-critical research activities that rely on DLS characterization and could result in delays to ongoing studies and cascading impacts on collaborating laboratories that depend on access to this capability.
The Government requires the complete system configuration, associated standards and consumables, installation, certification, training, and applicable technical support identified below.
CONTRACT TYPE
The Government intends to issue a Firm-Fixed-Price Purchase Order.
LINE ITEM / PRODUCT REQUIREMENTS
CLIN 0001 – Wyatt Systems DynaPro NanoStar II
Quantity: 1 Each
Part/Model No.: 176850550 1 WYATT Systems
Configuration shall include, at a minimum, the following:
- WDN-0200 – Quantity 1
DynaPro NanoStar II, 45 µL, Active USB. - 900113 – Quantity 2
1 mL ampule of Bovine Serum Albumin with lot certification. Concentration: 2 mg/mL. Provides molar mass validation and normalization for DAWN, miniDAWN, and microDAWN systems using an aqueous mobile phase and provides molar mass and size validation for DynaPro NanoStar, DynaPro Plate Reader, and related Wyatt instrumentation. - 900174 – Quantity 1
15 mL vial of aqueous suspension of polystyrene latex spheres for batch size and concentration validation for NanoStar, NanoStar II, ZetaStar, or Plate Reader. Certificates of Analysis and Safety Data Sheets are available through the manufacturer's documentation portal. - 900175 – Quantity 1
15 mL vial of aqueous suspension of polystyrene latex spheres for batch size and concentration validation for NanoStar, NanoStar II, ZetaStar, or Plate Reader. - 900107 – Quantity 1
Instrument Installation Kit. - 725000561 – Quantity 1
Ethernet Switch, 10/100/1000Base-T, 8-Port. - 900510 – Quantity 1
DYNAMICS 8 with DYNAMICS Touch. - WZDMC – Quantity 1
Package of 30 disposable cuvettes with 3 reusable caps for NanoStar II and ZetaStar. Cuvettes require a minimum sample volume of approximately 4 µL and are constructed of cyclic olefin copolymer (COC). - 741000536 – Quantity 1
Wyatt System Installation Certification. - Y-LSU2G – Quantity 1
Training, LSU – 2 Days. - 740007188 – Quantity 1
TAW DynaPro NS/NS with Online DLS.
The offeror shall provide pricing for all required items and associated services, including any applicable tariff charges, shipping, handling, installation, training, certification, and other associated costs.
APPLICABLE PROVISIONS AND CLAUSES
The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, dated March 13, 2026, unless otherwise stated in the resulting purchase order.
The associated NAICS code is 334516 – Analytical Laboratory Instrument Manufacturing, and the applicable small business size standard is 1,000 employees.
This requirement is not set aside for small business.
The provision at FAR 52.212-1, Instructions to Offerors—Commercial Products and Commercial Services, applies to this acquisition.
The provision at FAR 52.212-2, Evaluation—Commercial Products and Commercial Services, applies to this acquisition. The Government will evaluate quotations based on technical acceptability, price, delivery, and the offeror's ability to provide the required equipment, proprietary software, accessories, updates, installation, training, warranty, maintenance, and technical support.
The Government may make award based on the initial quotation received without conducting discussions.
A written notice of award or acceptance of an offer, issued to the successful offeror within the time specified in the offer, shall result in a binding contract without further action by either party.
The Government reserves the right to accept an offer before the expiration date specified in the offer, whether or not discussions are conducted, unless a written notice of withdrawal is received prior to award.
Offerors shall include a completed copy of FAR 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services, with their quotation.
FAR 52.212-4, Contract Terms and Conditions—Commercial Products and Commercial Services, applies to this acquisition.
FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Products and Commercial Services, applies to this acquisition.
The Defense Priorities and Allocations System (DPAS) is not applicable to this requirement.
SUBMISSION REQUIREMENTS
Responses shall include sufficient information to demonstrate the respondent's capability to provide the required products and services. Quotations shall include, at a minimum:
- Unit price;
- List price, if applicable;
- Shipping and handling costs;
- Delivery timeframe after award;
- Delivery terms;
- Prompt payment discount terms;
- F.O.B. point (destination or origin);
- Product, model, catalog, and/or part numbers;
- Product descriptions;
- Warranty and maintenance information; and
- Any other information relevant to the Government's evaluation.
Because this requirement involves proprietary Wyatt Systems equipment and compatibility with the NIH laboratory's existing Wyatt System, respondents shall provide documentation establishing that the offered products and services are supplied by, authorized by, or otherwise supported by Waters Technologies Corporation/Wyatt Technology and are compatible with the Government's existing Wyatt instrumentation and laboratory workflow.
Responses shall include, as applicable:
a. Product, catalog, model, and/or part number(s);
b. Product description;
c. Documentation demonstrating that the offered items meet the Government's required specifications and compatibility requirements;
d. Quantity;
e. Unit and extended pricing;
f. Shipping, handling, and installation charges;
g. Delivery timeframe after receipt of order;
h. Warranty and maintenance terms; and
i. Documentation establishing authorization to provide the specified proprietary Wyatt products and services if the respondent is not the manufacturer or authorized supplier.
Responses must also include the offeror's Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification.
All offerors must be actively registered in the System for Award Management (SAM) at the time of quotation submission and award.
RESPONSE DEADLINE
All responses must be received no later than September 21, 2026, at 9:00 a.m. Eastern Time.
Responses shall reference Solicitation No. 75N98026Q01220.
Responses shall be submitted electronically to:
patricia.haun@nih.gov
The Government intends to evaluate all information received in response to this notice and may make award based on the initial quotation without conducting discussions.
Overview
Award Overview
Possible prior contracts
Sign in to see possible prior contracts for this requirement (matched by agency, NAICS and place of performance; not confirmed).
Contacts
Contracting Officer
Primary Contact
Documents
No documents available.
Lifecycle
75N98026Q01220- Combined Synopsis
- Combined SynopsisCurrentSep 15, 2026
Dynamic Light Scattering Instrument Upgrade
Similar Opportunities
Title | Phase | Agency | NAICS | Set Aside | Posted | Deadline | Location |
|---|---|---|---|---|---|---|---|
NOTICE OF INTENT – SOLE-SOURCE ACQUISITION Notice No.: 75N98027Q00008 The National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI), intends to award a Firm-Fixed-Price Purchase Order to Aquaneering LLC for the retrofit and expansion of the Institute's existing aquatic housing system. Description of the Requirement NHGRI requires a retrofit of its existing Aquaneering aquatic housing system to convert eight underutilized genotyping rack positions to standard zebrafish housing. Upon completion, the retrofit is expected to provide capacity for 828 standard-sized tanks and more than 25,000 additional zebrafish. System Compatibility All supplied racks, containment trays, manifolds, gutters, valves, downspouts, flexible tubing, and retrofit plumbing must be fully compatible with the facility's existing Aquaneering central-filtration system and the tanks currently used by the facility. All flexible tubing and hoses must be black and fully opaque. Tanks are excluded from this acquisition. Rack Equipment The acquisition includes: Three AQC central-filtration double-sided 60-inch racks, model AQCF-D660-610, each with six shelves, 10-inch shelf spacing, and associated plumbing, with a finished height of approximately 89 inches before leveling. One AQC central-filtration double-sided 50-inch rack, model AQCF-D650-610, with six shelves, 10-inch shelf spacing, and associated plumbing, with a finished height of approximately 89 inches before leveling. Containment and Plumbing Components Six left-hand and six right-hand 50-inch containment catch trays. Eighteen left-hand and eighteen right-hand 60-inch containment catch trays. One custom supply-and-return retrofit plumbing kit for project S39397. Additional Components Six 18-valve water manifolds for 60-inch racks. Six 15-valve water manifolds for 50-inch racks. One six-shelf modular downspout assembly. Six 50-inch modular gutters. Six 60-inch modular gutters. Retrofit Configuration The work requires replacement of the existing row containing six single-sided back-to-back 0.8-liter racks and two single-sided back-to-back 1.8-liter racks. Two existing 56-inch 1.8-liter racks must also be relocated to the new row to replace two additional 0.8-liter racks. The final configuration and plumbing transitions must conform to the approved room layout and existing isolation points. Justification for the Proposed Sole-Source Acquisition The Government intends to solicit from a single source pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. Aquaneering LLC is the proposed source because the requirement involves modifying and expanding the facility's existing Aquaneering aquatic housing system while maintaining compatibility with its installed central-filtration infrastructure, plumbing interfaces, rack assemblies, and existing tanks. This acquisition involves more than the purchase of standalone aquarium racks. It requires an integrated retrofit consisting of specifically configured rack assemblies, matching containment trays, water manifolds, gutters, downspouts, and a custom supply-and-return plumbing kit designed to interface with the existing installation. The work also requires relocation of existing racks and integration of new and existing components within the facility's approved room layout and plumbing isolation points. Introducing components that are not fully compatible with the installed system could require additional engineering, modifications to existing plumbing, replacement of serviceable components, or changes to the approved room configuration. These changes could increase costs, introduce integration and operational risks, disrupt existing facility operations, and delay the planned expansion of zebrafish housing capacity. The Government therefore proposes to obtain the required equipment and retrofit components from Aquaneering LLC to maintain system compatibility and facilitate a coordinated expansion of the existing installation. The proposed sole-source approach is contingent upon the Government's determination, based on technical review and market research, that no other responsible source can satisfy all minimum technical and operational requirements. Response Information This notice is not a request for competitive quotations or proposals. However, interested parties that believe they can satisfy the Government's requirements may submit a capability statement demonstrating their ability to provide all required products and meet the specified technical and operational requirements. Capability statements should include sufficient technical information to demonstrate the firm's ability to: Provide rack assemblies and associated components that meet the specified dimensions, configurations, quantities, and performance requirements. Demonstrate full compatibility with the existing Aquaneering central-filtration system, existing tanks, and plumbing interfaces. Provide the required containment trays, manifolds, gutters, downspouts, flexible tubing, and custom supply-and-return retrofit plumbing. Accommodate the required rack relocation, plumbing transitions, approved room layout, and existing isolation points. Satisfy all other stated minimum technical and operational requirements. The Government will evaluate timely capability statements to determine whether another responsible source is capable of meeting the requirement and whether a competitive acquisition is appropriate. The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source can satisfy the requirement. Capability statements must be submitted electronically to haunp@mail.nih.gov no later than 9:00 a.m. EDT on October 22, 2026. Please reference Notice No. 75N98027Q00008 in the subject line of the submission. | Pre-Solicitation | 334516 | No Set-Aside | 10/13/2026 | 10/22/2026 | Bethesda, MD | |
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Fisher Scientific. Acquisition Description: The NIH Clinical Center, Department of Transfusion Medicine (DTM), Infectious Diseases Section requires acquisition of a 1) Real-Time PCR System, 2) an Automated Nucleic Acid Extractor and 3) a microvolume spectrophotometer to support clinical research and the development, optimization, and validation of diagnostic assays for hepatitis viruses and other transfusion-transmitted pathogens. The required system must support generation of high-quality quantification data from clinical specimens, including viral RNA/DNA and host-derived nucleic acids. The instrument must enable applications such as targeted genome amplification, work with a wider dynamic detection range, support the library prep for viral genome sequencing, and assay development workflows necessary for evaluating test performance and refining diagnostic methods prior to implementation in a clinical testing environment. The system must meet the following functional and operational requirements: High data accuracy and reproducibility to ensure reliable detection of viral variants and evaluation of assay performance; Low- to moderate-throughput capability appropriate for assay development, pilot studies, and validation activities involving smaller sample sets; Rapid turnaround times to support iterative testing and optimization of clinical assays; Flexible run configurations that allow efficient processing of varying sample volumes without excess capacity; Cost-efficient operation, including the ability to minimize per-run and per-sample costs for pathogen detection; Integrated and streamlined workflows, including nucleic acid extraction, amplification, quantification and data analysis within a platform from the same vendor to reduce complexity and variability; Ease of use and standardized operation, supporting reproducibility and implementation in a clinical laboratory environment; Compatibility with established nucleic acid preparation and amplification methods and existing laboratory workflows. The flexibility to be using the systems in a CLIA certified environment. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000121) by 12:00 PM eastern standard time on 10/23/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. | Special Notice | 334516 | No Set-Aside | 10/08/2026 | 10/23/2026 | Bethesda, MD | |
This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q00951/PCA-NIA-09016. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a firm fixed-price award to the responsible offeror whose proposal represents the best value to the Government. | Solicitation | 334516 | No Set-Aside | 08/05/2026 | 08/15/2026 | - | |
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: BD Biosciences. Acquisition Description: Flow cytometry is a critical technology used for immunophenotyping, cellular analysis, and functional assessment of immune cells in both clinical and research settings. Our laboratory’s BD FACSCanto™ II flow cytometer has been in service for an extended period and requires routine preventive maintenance and timely technical support to ensure reliable operation and minimize downtime. BD Biosciences is the manufacturer of the BD™ flow cytometry system and provides specialized maintenance services, technical expertise, and support specific to this system. The annual service agreement includes two preventive maintenance inspections and PM kits, one business day guaranteed response for emergency on-site service, unlimited service visits, software revisions released during the agreement period, and telephone support for instrument, reagents and application issues. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000233) by 12:00 PM eastern standard time on 10/23/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. | Special Notice | 334516 | No Set-Aside | 10/13/2026 | 10/23/2026 | Bethesda, MD | |
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Varian Medical Systems, Inc. Acquisition Description: The Clinical Center partners with the National Cancer Institute, Thoracic and Gastrointestinal Branch in offering diagnosis and treatment of cancer. The IntelliBlate Ximitry Probe is a specialized, single-use surgical instrument manufactured by Varian Medical Systems (a Siemens Healthineers company) designed for use with the IntelliBlate Microwave Ablation System. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000328) by 12:00 PM eastern standard time on 10/16/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. | Special Notice | 334516 | No Set-Aside | 10/09/2026 | 10/16/2026 | Bethesda, MD |
Additional Details
Solicitation Number
75N98026Q01220
Archive Date
Oct 6, 2026
Office Address
BETHESDA, MD, 20892